Odicino F

No ORCID on file · 8 papers in corpus
diagnostic-accuracy 2026
Human Reproduction ·doi:10.1093/humrep/deaf221

STUDY QUESTION: Can a serum miRNA signature serve as a potential diagnostic biomarker for endometriosis (END)? SUMMARY ANSWER: A miRNA-based diagnostic model demonstrated an accuracy of 65.8% in distinguishing END patients from control sub…

meta-analysis 2025
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70164

BACKGROUND: OHVIRA syndrome, a urogenital malformation, lacks standardized management. Narrative reviews exist, but there is no a comprehensive meta-analysis. OBJECTIVES: The aim of this first systematic review and meta-analysis is to eval…

observational 2024
Women's health (London, England) ·doi:10.1177/17455057241252573

BACKGROUND: Almost 10% of women in reproductive age are diagnosed with ovarian endometriomas and can experience symptoms and infertility disorders. Ovarian endometriomas can be treated with medical or surgical therapy. OBJECTIVE: To assess…

review 2024
Frontiers in medicine ·doi:10.3389/fmed.2024.1387036

Endometriosis is a chronic debilitating disease that affects nearly 10% of women of the reproductive age. Although the treatment modalities of endometriosis are numerous, surgical excision of the endometriotic implants and nodules remains t…

2021
meta-analysis 2021
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14635

AIM: The scar of cesarean section (CS) is the most common site of abdominal wall endometriosis (AWE), whose tumor degeneration has been reported in an increasing number of cases; the most frequent histological type is clear cell carcinoma (…

review 2020
Journal of clinical medicine ·doi:10.3390/jcm9082552

BACKGROUND: Intestinal metaplasia/differentiation in primary endometrial carcinomas is an uncommon phenomenon, with only few cases described. MATERIAL AND METHODS: We performed a systematic review of endometrial carcinomas with intestinal …

other 2017
Journal of experimental & clinical cancer research : CR ·doi:10.1186/s13046-017-0536-y

BACKGROUND: Epithelial ovarian cancer (EOC) is a spectrum of different diseases, which makes their treatment a challenge. Forkhead box M1 (FOXM1) is an oncogene aberrantly expressed in many solid cancers including serous EOC, but its role i…